Cyclosporine insert removes compliance issue from dry eye disease treatment

[ad_1]

August 12, 2021

1 min watch


We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected].

LAS VEGAS — In this Healio Video Perspective from the ASCRS meeting, Lee Shettle, DO, discusses results from a phase 1 trial investigating a novel hydrogel-based cyclosporine insert for the treatment of dry eye disease.

[ad_2]

Source link

Elena Johaness

Leave a Reply

Your email address will not be published.